Global Seasonal Influenza Vaccines Therapeutics Market Research Report 2025(Status and Outlook)

October 2025 | 146 pages | ID: GD5693C0C5DDEN
Bosson Research

Abstracts

Report Overview

Seasonal influenza vaccines are medical products used to prevent influenza virus infection and reduce the severity of flu symptoms during flu seasons.

The global Seasonal Influenza Vaccines Therapeutics market size was estimated at USD 6981.45 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 6.85% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Seasonal Influenza Vaccines Therapeutics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Seasonal Influenza Vaccines Therapeutics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Seasonal Influenza Vaccines Therapeutics market

Global Seasonal Influenza Vaccines Therapeutics Market: Market Segmentation Analysis


This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

GSK
Novartis
CSL
MedImmune
Sanofi-Pasteur
Solvay
Hualan Biological Engineering
Sinovac Biotech
Changchun Institute of Biological Products Co.Ltd.
Shanghai Institute of Biological Products Co.Ltd.

Market Segmentation (by Type)

Paediatrics
Adolescence
Adults
Elderly

Market Segmentation (by Application)

Hospitals
Clinics
Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Seasonal Influenza Vaccines Therapeutics Market
• Overview of the regional outlook of the Seasonal Influenza Vaccines Therapeutics Market.

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Seasonal Influenza Vaccines Therapeutics Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Seasonal Influenza Vaccines Therapeutics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Seasonal Influenza Vaccines Therapeutics
1.2 Key Market Segments
  1.2.1 Seasonal Influenza Vaccines Therapeutics Segment by Type
  1.2.2 Seasonal Influenza Vaccines Therapeutics Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 SEASONAL INFLUENZA VACCINES THERAPEUTICS MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Seasonal Influenza Vaccines Therapeutics Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Seasonal Influenza Vaccines Therapeutics Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 SEASONAL INFLUENZA VACCINES THERAPEUTICS MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Seasonal Influenza Vaccines Therapeutics Product Life Cycle
3.3 Global Seasonal Influenza Vaccines Therapeutics Sales by Manufacturers (2020-2025)
3.4 Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Manufacturers (2020-2025)
3.5 Seasonal Influenza Vaccines Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Seasonal Influenza Vaccines Therapeutics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Seasonal Influenza Vaccines Therapeutics Market Competitive Situation and Trends
  3.8.1 Seasonal Influenza Vaccines Therapeutics Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Seasonal Influenza Vaccines Therapeutics Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 SEASONAL INFLUENZA VACCINES THERAPEUTICS INDUSTRY CHAIN ANALYSIS

4.1 Seasonal Influenza Vaccines Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF SEASONAL INFLUENZA VACCINES THERAPEUTICS MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Seasonal Influenza Vaccines Therapeutics Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy ? April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Seasonal Influenza Vaccines Therapeutics Market
5.7 ESG Ratings of Leading Companies

6 SEASONAL INFLUENZA VACCINES THERAPEUTICS MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Seasonal Influenza Vaccines Therapeutics Sales Market Share by Type (2020-2025)
6.3 Global Seasonal Influenza Vaccines Therapeutics Market Size Market Share by Type (2020-2025)
6.4 Global Seasonal Influenza Vaccines Therapeutics Price by Type (2020-2025)

7 SEASONAL INFLUENZA VACCINES THERAPEUTICS MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Seasonal Influenza Vaccines Therapeutics Market Sales by Application (2020-2025)
7.3 Global Seasonal Influenza Vaccines Therapeutics Market Size (M USD) by Application (2020-2025)
7.4 Global Seasonal Influenza Vaccines Therapeutics Sales Growth Rate by Application (2020-2025)

8 SEASONAL INFLUENZA VACCINES THERAPEUTICS MARKET SALES BY REGION

8.1 Global Seasonal Influenza Vaccines Therapeutics Sales by Region
  8.1.1 Global Seasonal Influenza Vaccines Therapeutics Sales by Region
  8.1.2 Global Seasonal Influenza Vaccines Therapeutics Sales Market Share by Region
8.2 Global Seasonal Influenza Vaccines Therapeutics Market Size by Region
  8.2.1 Global Seasonal Influenza Vaccines Therapeutics Market Size by Region
  8.2.2 Global Seasonal Influenza Vaccines Therapeutics Market Size Market Share by Region
8.3 North America
  8.3.1 North America Seasonal Influenza Vaccines Therapeutics Sales by Country
  8.3.2 North America Seasonal Influenza Vaccines Therapeutics Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Seasonal Influenza Vaccines Therapeutics Sales by Country
  8.4.2 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Seasonal Influenza Vaccines Therapeutics Sales by Region
  8.5.2 Asia Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Seasonal Influenza Vaccines Therapeutics Sales by Country
  8.6.2 South America Seasonal Influenza Vaccines Therapeutics Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Seasonal Influenza Vaccines Therapeutics Sales by Region
  8.7.2 Middle East and Africa Seasonal Influenza Vaccines Therapeutics Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 SEASONAL INFLUENZA VACCINES THERAPEUTICS MARKET PRODUCTION BY REGION

9.1 Global Production of Seasonal Influenza Vaccines Therapeutics by Region(2020-2025)
9.2 Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Region (2020-2025)
9.3 Global Seasonal Influenza Vaccines Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Seasonal Influenza Vaccines Therapeutics Production
  9.4.1 North America Seasonal Influenza Vaccines Therapeutics Production Growth Rate (2020-2025)
  9.4.2 North America Seasonal Influenza Vaccines Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Seasonal Influenza Vaccines Therapeutics Production
  9.5.1 Europe Seasonal Influenza Vaccines Therapeutics Production Growth Rate (2020-2025)
  9.5.2 Europe Seasonal Influenza Vaccines Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Seasonal Influenza Vaccines Therapeutics Production (2020-2025)
  9.6.1 Japan Seasonal Influenza Vaccines Therapeutics Production Growth Rate (2020-2025)
  9.6.2 Japan Seasonal Influenza Vaccines Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Seasonal Influenza Vaccines Therapeutics Production (2020-2025)
  9.7.1 China Seasonal Influenza Vaccines Therapeutics Production Growth Rate (2020-2025)
  9.7.2 China Seasonal Influenza Vaccines Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 GSK
  10.1.1 GSK Basic Information
  10.1.2 GSK Seasonal Influenza Vaccines Therapeutics Product Overview
  10.1.3 GSK Seasonal Influenza Vaccines Therapeutics Product Market Performance
  10.1.4 GSK Business Overview
  10.1.5 GSK SWOT Analysis
  10.1.6 GSK Recent Developments
10.2 Novartis
  10.2.1 Novartis Basic Information
  10.2.2 Novartis Seasonal Influenza Vaccines Therapeutics Product Overview
  10.2.3 Novartis Seasonal Influenza Vaccines Therapeutics Product Market Performance
  10.2.4 Novartis Business Overview
  10.2.5 Novartis SWOT Analysis
  10.2.6 Novartis Recent Developments
10.3 CSL
  10.3.1 CSL Basic Information
  10.3.2 CSL Seasonal Influenza Vaccines Therapeutics Product Overview
  10.3.3 CSL Seasonal Influenza Vaccines Therapeutics Product Market Performance
  10.3.4 CSL Business Overview
  10.3.5 CSL SWOT Analysis
  10.3.6 CSL Recent Developments
10.4 MedImmune
  10.4.1 MedImmune Basic Information
  10.4.2 MedImmune Seasonal Influenza Vaccines Therapeutics Product Overview
  10.4.3 MedImmune Seasonal Influenza Vaccines Therapeutics Product Market Performance
  10.4.4 MedImmune Business Overview
  10.4.5 MedImmune Recent Developments
10.5 Sanofi-Pasteur
  10.5.1 Sanofi-Pasteur Basic Information
  10.5.2 Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Product Overview
  10.5.3 Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Product Market Performance
  10.5.4 Sanofi-Pasteur Business Overview
  10.5.5 Sanofi-Pasteur Recent Developments
10.6 Solvay
  10.6.1 Solvay Basic Information
  10.6.2 Solvay Seasonal Influenza Vaccines Therapeutics Product Overview
  10.6.3 Solvay Seasonal Influenza Vaccines Therapeutics Product Market Performance
  10.6.4 Solvay Business Overview
  10.6.5 Solvay Recent Developments
10.7 Hualan Biological Engineering
  10.7.1 Hualan Biological Engineering Basic Information
  10.7.2 Hualan Biological Engineering Seasonal Influenza Vaccines Therapeutics Product Overview
  10.7.3 Hualan Biological Engineering Seasonal Influenza Vaccines Therapeutics Product Market Performance
  10.7.4 Hualan Biological Engineering Business Overview
  10.7.5 Hualan Biological Engineering Recent Developments
10.8 Sinovac Biotech
  10.8.1 Sinovac Biotech Basic Information
  10.8.2 Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Product Overview
  10.8.3 Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Product Market Performance
  10.8.4 Sinovac Biotech Business Overview
  10.8.5 Sinovac Biotech Recent Developments
10.9 Changchun Institute of Biological Products Co.Ltd.
  10.9.1 Changchun Institute of Biological Products Co.Ltd. Basic Information
  10.9.2 Changchun Institute of Biological Products Co.Ltd. Seasonal Influenza Vaccines Therapeutics Product Overview
  10.9.3 Changchun Institute of Biological Products Co.Ltd. Seasonal Influenza Vaccines Therapeutics Product Market Performance
  10.9.4 Changchun Institute of Biological Products Co.Ltd. Business Overview
  10.9.5 Changchun Institute of Biological Products Co.Ltd. Recent Developments
10.10 Shanghai Institute of Biological Products Co.Ltd.
  10.10.1 Shanghai Institute of Biological Products Co.Ltd. Basic Information
  10.10.2 Shanghai Institute of Biological Products Co.Ltd. Seasonal Influenza Vaccines Therapeutics Product Overview
  10.10.3 Shanghai Institute of Biological Products Co.Ltd. Seasonal Influenza Vaccines Therapeutics Product Market Performance
  10.10.4 Shanghai Institute of Biological Products Co.Ltd. Business Overview
  10.10.5 Shanghai Institute of Biological Products Co.Ltd. Recent Developments

11 SEASONAL INFLUENZA VACCINES THERAPEUTICS MARKET FORECAST BY REGION

11.1 Global Seasonal Influenza Vaccines Therapeutics Market Size Forecast
11.2 Global Seasonal Influenza Vaccines Therapeutics Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Seasonal Influenza Vaccines Therapeutics Market Size Forecast by Country
  11.2.3 Asia Pacific Seasonal Influenza Vaccines Therapeutics Market Size Forecast by Region
  11.2.4 South America Seasonal Influenza Vaccines Therapeutics Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Seasonal Influenza Vaccines Therapeutics by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)

12.1 Global Seasonal Influenza Vaccines Therapeutics Market Forecast by Type (2026-2033)
  12.1.1 Global Forecasted Sales of Seasonal Influenza Vaccines Therapeutics by Type (2026-2033)
  12.1.2 Global Seasonal Influenza Vaccines Therapeutics Market Size Forecast by Type (2026-2033)
  12.1.3 Global Forecasted Price of Seasonal Influenza Vaccines Therapeutics by Type (2026-2033)
12.2 Global Seasonal Influenza Vaccines Therapeutics Market Forecast by Application (2026-2033)
  12.2.1 Global Seasonal Influenza Vaccines Therapeutics Sales (K MT) Forecast by Application
  12.2.2 Global Seasonal Influenza Vaccines Therapeutics Market Size (M USD) Forecast by Application (2026-2033)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Seasonal Influenza Vaccines Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Seasonal Influenza Vaccines Therapeutics Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Seasonal Influenza Vaccines Therapeutics Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Seasonal Influenza Vaccines Therapeutics Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Seasonal Influenza Vaccines Therapeutics Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Seasonal Influenza Vaccines Therapeutics as of 2024)
Table 10. Global Market Seasonal Influenza Vaccines Therapeutics Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Seasonal Influenza Vaccines Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Seasonal Influenza Vaccines Therapeutics Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Seasonal Influenza Vaccines Therapeutics Sales by Type (K MT)
Table 26. Global Seasonal Influenza Vaccines Therapeutics Market Size by Type (M USD)
Table 27. Global Seasonal Influenza Vaccines Therapeutics Sales (K MT) by Type (2020-2025)
Table 28. Global Seasonal Influenza Vaccines Therapeutics Sales Market Share by Type (2020-2025)
Table 29. Global Seasonal Influenza Vaccines Therapeutics Market Size (M USD) by Type (2020-2025)
Table 30. Global Seasonal Influenza Vaccines Therapeutics Market Size Share by Type (2020-2025)
Table 31. Global Seasonal Influenza Vaccines Therapeutics Price (USD/KG) by Type (2020-2025)
Table 32. Global Seasonal Influenza Vaccines Therapeutics Sales (K MT) by Application
Table 33. Global Seasonal Influenza Vaccines Therapeutics Market Size by Application
Table 34. Global Seasonal Influenza Vaccines Therapeutics Sales by Application (2020-2025) & (K MT)
Table 35. Global Seasonal Influenza Vaccines Therapeutics Sales Market Share by Application (2020-2025)
Table 36. Global Seasonal Influenza Vaccines Therapeutics Market Size by Application (2020-2025) & (M USD)
Table 37. Global Seasonal Influenza Vaccines Therapeutics Market Share by Application (2020-2025)
Table 38. Global Seasonal Influenza Vaccines Therapeutics Sales Growth Rate by Application (2020-2025)
Table 39. Global Seasonal Influenza Vaccines Therapeutics Sales by Region (2020-2025) & (K MT)
Table 40. Global Seasonal Influenza Vaccines Therapeutics Sales Market Share by Region (2020-2025)
Table 41. Global Seasonal Influenza Vaccines Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 42. Global Seasonal Influenza Vaccines Therapeutics Market Size Market Share by Region (2020-2025)
Table 43. North America Seasonal Influenza Vaccines Therapeutics Sales by Country (2020-2025) & (K MT)
Table 44. North America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Seasonal Influenza Vaccines Therapeutics Sales by Country (2020-2025) & (K MT)
Table 46. Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Seasonal Influenza Vaccines Therapeutics Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 49. South America Seasonal Influenza Vaccines Therapeutics Sales by Country (2020-2025) & (K MT)
Table 50. South America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Seasonal Influenza Vaccines Therapeutics Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Seasonal Influenza Vaccines Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 53. Global Seasonal Influenza Vaccines Therapeutics Production (K MT) by Region(2020-2025)
Table 54. Global Seasonal Influenza Vaccines Therapeutics Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Region (2020-2025)
Table 56. Global Seasonal Influenza Vaccines Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Seasonal Influenza Vaccines Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Seasonal Influenza Vaccines Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Seasonal Influenza Vaccines Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Seasonal Influenza Vaccines Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. GSK Basic Information
Table 62. GSK Seasonal Influenza Vaccines Therapeutics Product Overview
Table 63. GSK Seasonal Influenza Vaccines Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. GSK Business Overview
Table 65. GSK SWOT Analysis
Table 66. GSK Recent Developments
Table 67. Novartis Basic Information
Table 68. Novartis Seasonal Influenza Vaccines Therapeutics Product Overview
Table 69. Novartis Seasonal Influenza Vaccines Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Novartis Business Overview
Table 71. Novartis SWOT Analysis
Table 72. Novartis Recent Developments
Table 73. CSL Basic Information
Table 74. CSL Seasonal Influenza Vaccines Therapeutics Product Overview
Table 75. CSL Seasonal Influenza Vaccines Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. CSL Business Overview
Table 77. CSL SWOT Analysis
Table 78. CSL Recent Developments
Table 79. MedImmune Basic Information
Table 80. MedImmune Seasonal Influenza Vaccines Therapeutics Product Overview
Table 81. MedImmune Seasonal Influenza Vaccines Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. MedImmune Business Overview
Table 83. MedImmune Recent Developments
Table 84. Sanofi-Pasteur Basic Information
Table 85. Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Product Overview
Table 86. Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. Sanofi-Pasteur Business Overview
Table 88. Sanofi-Pasteur Recent Developments
Table 89. Solvay Basic Information
Table 90. Solvay Seasonal Influenza Vaccines Therapeutics Product Overview
Table 91. Solvay Seasonal Influenza Vaccines Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. Solvay Business Overview
Table 93. Solvay Recent Developments
Table 94. Hualan Biological Engineering Basic Information
Table 95. Hualan Biological Engineering Seasonal Influenza Vaccines Therapeutics Product Overview
Table 96. Hualan Biological Engineering Seasonal Influenza Vaccines Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. Hualan Biological Engineering Business Overview
Table 98. Hualan Biological Engineering Recent Developments
Table 99. Sinovac Biotech Basic Information
Table 100. Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Product Overview
Table 101. Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. Sinovac Biotech Business Overview
Table 103. Sinovac Biotech Recent Developments
Table 104. Changchun Institute of Biological Products Co.Ltd. Basic Information
Table 105. Changchun Institute of Biological Products Co.Ltd. Seasonal Influenza Vaccines Therapeutics Product Overview
Table 106. Changchun Institute of Biological Products Co.Ltd. Seasonal Influenza Vaccines Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. Changchun Institute of Biological Products Co.Ltd. Business Overview
Table 108. Changchun Institute of Biological Products Co.Ltd. Recent Developments
Table 109. Shanghai Institute of Biological Products Co.Ltd. Basic Information
Table 110. Shanghai Institute of Biological Products Co.Ltd. Seasonal Influenza Vaccines Therapeutics Product Overview
Table 111. Shanghai Institute of Biological Products Co.Ltd. Seasonal Influenza Vaccines Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 112. Shanghai Institute of Biological Products Co.Ltd. Business Overview
Table 113. Shanghai Institute of Biological Products Co.Ltd. Recent Developments
Table 114. Global Seasonal Influenza Vaccines Therapeutics Sales Forecast by Region (2026-2033) & (K MT)
Table 115. Global Seasonal Influenza Vaccines Therapeutics Market Size Forecast by Region (2026-2033) & (M USD)
Table 116. North America Seasonal Influenza Vaccines Therapeutics Sales Forecast by Country (2026-2033) & (K MT)
Table 117. North America Seasonal Influenza Vaccines Therapeutics Market Size Forecast by Country (2026-2033) & (M USD)
Table 118. Europe Seasonal Influenza Vaccines Therapeutics Sales Forecast by Country (2026-2033) & (K MT)
Table 119. Europe Seasonal Influenza Vaccines Therapeutics Market Size Forecast by Country (2026-2033) & (M USD)
Table 120. Asia Pacific Seasonal Influenza Vaccines Therapeutics Sales Forecast by Region (2026-2033) & (K MT)
Table 121. Asia Pacific Seasonal Influenza Vaccines Therapeutics Market Size Forecast by Region (2026-2033) & (M USD)
Table 122. South America Seasonal Influenza Vaccines Therapeutics Sales Forecast by Country (2026-2033) & (K MT)
Table 123. South America Seasonal Influenza Vaccines Therapeutics Market Size Forecast by Country (2026-2033) & (M USD)
Table 124. Middle East and Africa Seasonal Influenza Vaccines Therapeutics Sales Forecast by Country (2026-2033) & (Units)
Table 125. Middle East and Africa Seasonal Influenza Vaccines Therapeutics Market Size Forecast by Country (2026-2033) & (M USD)
Table 126. Global Seasonal Influenza Vaccines Therapeutics Sales Forecast by Type (2026-2033) & (K MT)
Table 127. Global Seasonal Influenza Vaccines Therapeutics Market Size Forecast by Type (2026-2033) & (M USD)
Table 128. Global Seasonal Influenza Vaccines Therapeutics Price Forecast by Type (2026-2033) & (USD/KG)
Table 129. Global Seasonal Influenza Vaccines Therapeutics Sales (K MT) Forecast by Application (2026-2033)
Table 130. Global Seasonal Influenza Vaccines Therapeutics Market Size Forecast by Application (2026-2033) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Seasonal Influenza Vaccines Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Seasonal Influenza Vaccines Therapeutics Market Size (M USD), 2024-2033
Figure 5. Global Seasonal Influenza Vaccines Therapeutics Market Size (M USD) (2020-2033)
Figure 6. Global Seasonal Influenza Vaccines Therapeutics Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Seasonal Influenza Vaccines Therapeutics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Seasonal Influenza Vaccines Therapeutics Product Life Cycle
Figure 13. Seasonal Influenza Vaccines Therapeutics Sales Share by Manufacturers in 2024
Figure 14. Global Seasonal Influenza Vaccines Therapeutics Revenue Share by Manufacturers in 2024
Figure 15. Seasonal Influenza Vaccines Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Seasonal Influenza Vaccines Therapeutics Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Seasonal Influenza Vaccines Therapeutics Revenue in 2024
Figure 18. Industry Chain Map of Seasonal Influenza Vaccines Therapeutics
Figure 19. Global Seasonal Influenza Vaccines Therapeutics Market PEST Analysis
Figure 20. Global Seasonal Influenza Vaccines Therapeutics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Seasonal Influenza Vaccines Therapeutics Market Share by Type
Figure 27. Sales Market Share of Seasonal Influenza Vaccines Therapeutics by Type (2020-2025)
Figure 28. Sales Market Share of Seasonal Influenza Vaccines Therapeutics by Type in 2024
Figure 29. Market Size Share of Seasonal Influenza Vaccines Therapeutics by Type (2020-2025)
Figure 30. Market Size Share of Seasonal Influenza Vaccines Therapeutics by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Seasonal Influenza Vaccines Therapeutics Market Share by Application
Figure 33. Global Seasonal Influenza Vaccines Therapeutics Sales Market Share by Application (2020-2025)
Figure 34. Global Seasonal Influenza Vaccines Therapeutics Sales Market Share by Application in 2024
Figure 35. Global Seasonal Influenza Vaccines Therapeutics Market Share by Application (2020-2025)
Figure 36. Global Seasonal Influenza Vaccines Therapeutics Market Share by Application in 2024
Figure 37. Global Seasonal Influenza Vaccines Therapeutics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Seasonal Influenza Vaccines Therapeutics Sales Market Share by Region (2020-2025)
Figure 39. Global Seasonal Influenza Vaccines Therapeutics Market Size Market Share by Region (2020-2025)
Figure 40. North America Seasonal Influenza Vaccines Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Seasonal Influenza Vaccines Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Seasonal Influenza Vaccines Therapeutics Sales Market Share by Country in 2024
Figure 43. North America Seasonal Influenza Vaccines Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Seasonal Influenza Vaccines Therapeutics Market Size Market Share by Country in 2024
Figure 45. U.S. Seasonal Influenza Vaccines Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Seasonal Influenza Vaccines Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Seasonal Influenza Vaccines Therapeutics Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Seasonal Influenza Vaccines Therapeutics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Seasonal Influenza Vaccines Therapeutics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Seasonal Influenza Vaccines Therapeutics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Seasonal Influenza Vaccines Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Seasonal Influenza Vaccines Therapeutics Sales Market Share by Country in 2024
Figure 53. Europe Seasonal Influenza Vaccines Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Seasonal Influenza Vaccines Therapeutics Market Size Market Share by Country in 2024
Figure 55. Germany Seasonal Influenza Vaccines Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Seasonal Influenza Vaccines Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Seasonal Influenza Vaccines Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Seasonal Influenza Vaccines Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Seasonal Influenza Vaccines Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Seasonal Influenza Vaccines Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Seasonal Influenza Vaccines Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Seasonal Influenza Vaccines Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Seasonal Influenza Vaccines Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Seasonal Influenza Vaccines Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Seasonal Influenza Vaccines Therapeutics Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Seasonal Influenza Vaccines Therapeutics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Seasonal Influenza Vaccines Therapeutics Market Size Market Share by Region in 2024
Figure 68. China Seasonal Influenza Vaccines Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Seasonal Influenza Vaccines Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Seasonal Influenza Vaccines Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Seasonal Influenza Vaccines Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Seasonal Influenza Vaccines Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Seasonal Influenza Vaccines Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Seasonal Influenza Vaccines Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Seasonal Influenza Vaccines Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Seasonal Influenza Vaccines Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Seasonal Influenza Vaccines Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Seasonal Influenza Vaccines Therapeutics Sales and Growth Rate (K MT)
Figure 79. South America Seasonal Influenza Vaccines Therapeutics Sales Market Share by Country in 2024
Figure 80. South America Seasonal Influenza Vaccines Therapeutics Market Size and Growth Rate (M USD)
Figure 81. South America Seasonal Influenza Vaccines Therapeutics Market Size Market Share by Country in 2024
Figure 82. Brazil Seasonal Influenza Vaccines Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Seasonal Influenza Vaccines Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Seasonal Influenza Vaccines Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Seasonal Influenza Vaccines Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Seasonal Influenza Vaccines Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Seasonal Influenza Vaccines Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Seasonal Influenza Vaccines Therapeutics Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Seasonal Influenza Vaccines Therapeutics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Seasonal Influenza Vaccines Therapeutics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Seasonal Influenza Vaccines Therapeutics Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Seasonal Influenza Vaccines Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Seasonal Influenza Vaccines Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Seasonal Influenza Vaccines Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Seasonal Influenza Vaccines Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Seasonal Influenza Vaccines Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Seasonal Influenza Vaccines Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Seasonal Influenza Vaccines Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Seasonal Influenza Vaccines Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Seasonal Influenza Vaccines Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Seasonal Influenza Vaccines Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Seasonal Influenza Vaccines Therapeutics Production Market Share by Region (2020-2025)
Figure 103. North America Seasonal Influenza Vaccines Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Seasonal Influenza Vaccines Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Seasonal Influenza Vaccines Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 106. China Seasonal Influenza Vaccines Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Seasonal Influenza Vaccines Therapeutics Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Seasonal Influenza Vaccines Therapeutics Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Seasonal Influenza Vaccines Therapeutics Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Seasonal Influenza Vaccines Therapeutics Market Share Forecast by Type (2026-2033)
Figure 111. Global Seasonal Influenza Vaccines Therapeutics Sales Forecast by Application (2026-2033)
Figure 112. Global Seasonal Influenza Vaccines Therapeutics Market Share Forecast by Application (2026-2033)